Cytosorbents (CTSO) Non-Current Assets (2010 - 2026)
Cytosorbents posted quarterly Non-Current Assets of $22.8 million for Q1 2026, down 10.11% year-on-year from $25.4 million in Q1 2025, and down 3.16% on a QoQ basis from $23.5 million in Q4 2025.
Cytosorbents (CTSO) has 17 years of Non-Current Assets data on file, last reported at $22.8 million in Q1 2026.
- For the quarter ending Q1 2026, Non-Current Assets fell 10.11% year-over-year to $22.8 million; the trailing twelve-month figure through Mar 2026 stood at $95.8 million (down 15.83% YoY), and the FY2025 full-year result was $23.5 million, down 8.62% from the prior year.
- Non-Current Assets for Q1 2026 stood at $22.8 million, down from $23.5 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $31.5 million in Q2 2024 and bottomed at $22.8 million in Q1 2026.
- The 5-year median for Non-Current Assets is $27.6 million (2023), against an average of $27.5 million.
- The widest annual swing landed in 2022, when Non-Current Assets jumped 249.53%; it then decreased 21.69% in 2025.
- A 5-year view of Non-Current Assets shows it stood at $29.5 million in 2022, then dropped by 6.49% to $27.6 million in 2023, then retreated by 6.49% to $25.8 million in 2024, then dropped by 8.62% to $23.5 million in 2025, then decreased by 3.16% to $22.8 million in 2026.
- The last three Non-Current Assets figures came in at $22.8 million (Q1 2026), $23.5 million (Q4 2025), and $24.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 84.92 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 32.95 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 67.41 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 35.67 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 7.09 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 20.47 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2.30 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 26.70 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 8.34 Bn |
| 10 | Cytosorbents | 28.81 Mn | 24.01 Mn | 6.13 Mn | 22.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.81 Mn |
| Dec 31, 2025 | 23.55 Mn |
| Sep 30, 2025 | 24.44 Mn |
| Jun 30, 2025 | 25.00 Mn |
| Mar 31, 2025 | 25.37 Mn |
| Dec 31, 2024 | 25.77 Mn |
| Sep 30, 2024 | 31.21 Mn |
| Jun 30, 2024 | 31.47 Mn |
| Mar 31, 2024 | 27.08 Mn |
| Dec 31, 2023 | 27.56 Mn |
| Sep 30, 2023 | 28.31 Mn |
| Jun 30, 2023 | 28.80 Mn |
| Mar 31, 2023 | 29.30 Mn |
| Dec 31, 2022 | 29.47 Mn |
| Sep 30, 2022 | 29.89 Mn |
| Jun 30, 2022 | 29.56 Mn |
| Mar 31, 2022 | 27.42 Mn |
| Dec 31, 2021 | 25.22 Mn |
| Sep 30, 2021 | 22.32 Mn |
| Jun 30, 2021 | 21.11 Mn |
| Mar 31, 2021 | 7.84 Mn |
| Dec 31, 2020 | 7.50 Mn |
| Sep 30, 2020 | 7.48 Mn |
| Jun 30, 2020 | 7.31 Mn |
| Mar 31, 2020 | 6.70 Mn |
| Dec 31, 2019 | 6.48 Mn |
| Sep 30, 2019 | 6.33 Mn |
| Jun 30, 2019 | 6.27 Mn |
| Mar 31, 2019 | 6.17 Mn |
| Dec 31, 2018 | 5.93 Mn |
| Sep 30, 2018 | 4.30 Mn |
| Jun 30, 2018 | 4.17 Mn |
| Mar 31, 2018 | 3.79 Mn |
| Dec 31, 2017 | 3.36 Mn |
| Sep 30, 2017 | 2.83 Mn |
| Jun 30, 2017 | 2.35 Mn |
| Mar 31, 2017 | 2.01 Mn |
| Dec 31, 2016 | 1.87 Mn |
| Sep 30, 2016 | 1.80 Mn |
| Jun 30, 2016 | 1.64 Mn |
| Mar 31, 2016 | 1.47 Mn |
| Dec 31, 2015 | 1.39 Mn |
| Dec 31, 2014 | 861,619.00 |
| Sep 30, 2014 | 672,144.00 |
| Jun 30, 2014 | 634,578.00 |
| Mar 31, 2014 | 565,088.00 |
| Dec 31, 2013 | 558,768.00 |
| Sep 30, 2013 | 394,942.00 |
| Jun 30, 2013 | 394,111.00 |
| Mar 31, 2013 | 397,303.00 |
| Dec 31, 2012 | 399,820.00 |
| Sep 30, 2012 | 413,017.00 |
| Jun 30, 2012 | 429,668.00 |
| Mar 31, 2012 | 425,633.00 |
| Dec 31, 2011 | 425,061.00 |
| Sep 30, 2011 | 418,433.00 |
| Jun 30, 2011 | 410,339.00 |
| Dec 31, 2010 | 411,721.00 |